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INTRODUCTION
The International Classification of Headache
Disorders defines trigeminal neuralgia (TN)
as “A disorder characterized by recurrent
unilateral brief electric shock-like pain,
abrupt in onset and termination, limited
to the distribution of one or more di-
visions of the trigeminal nerve and trig-
gered by innocuous stimuli.”1 It is a rare
condition, and population-based studies
estimate a prevalence ranging from 0.03%
(95% confidence interval 0.01e0.08) to
0.3% (95% confidence interval 0.16e
0.55).2 It remains one of the few
neuropathic pain conditions for which
multiple therapies, including medical
and surgical, are available. However, the
best treatment option has yet to be
identified. The difficulty in defining what
the most successful treatment for TN is
relates to the fact that there are no
clearly defined outcomes; therefore,
comparison between treatments is
challenging. Outcomes are defined as
measures or observations, which are
used to assess treatment effects.3 For the
purpose of this review, outcome refers to
clinical outcome, which is the result(s) of
the medical or surgical treatment of TN
on the patient’s health or well-being. To
improve comparison of treatments, clearly
defined outcomes (what is assessed) and
outcomes measures (how to assess
outcome magnitude) should be used.
Outcome measures are tools used to
assess the impact of treatment
interventions.
The variability in instruments used to
measure treatment outcomes contributes
to the difficulties in appraising research
results.3 These difficulties are a reality for
clinicians and patients and result in
uncertainty when faced with multiple
treatment options.
To minimize the discrepancy between
studies and results, groups of researchers
and clinicians have developed guidelines
for the systematic reporting of outcome
measures. One such example is the
Initiative on Methods, Measurement, and
Pain Assessment in Clinical Trials
(IMMPACT), which has developed rec-
ommendations for core outcome domains
to be reported in clinical trials of pain
disorders.4
There have been studies reporting on
the use of outcome measures in individual
TN treatments, but there has not been a
comprehensive review looking at all med-
ical and surgical treatments published to
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date. The aim of this systematic review
was, therefore, to summarize all the
treatment outcomes used in the TN liter-
ature, to highlight the variability in their
reporting, and, additionally, to summarize
the instruments used to measure those
outcomes.
METHODS
A protocol for the systematic review was
published in the International Prospective
Registry of Systematic Reviews (PROS-
PERO) (Registration CRD42018118675,
December 2018) and followed recommen-
dations of the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses
group.5
Search Strategy
A literature search was conducted to
include all TN studies in which there was a
medical and/or a surgical intervention
with a view to capturing all treatment
outcomes and the outcome measures
used. The searches were performed elec-
tronically, with the help of a librarian, and
by hand. We searched MEDLINE (Ovid)
(1946 to October 2019 for medical treat-
ment and 2008 to October 2019 for surgi-
cal treatment), EMBASE (1947 to October
2019 for medical treatment and 2008 to
October 2019 for surgical treatment),
Cochrane Oral Health Group’s Trials
Register, CINAHL Plus with Full Text, and
PsycINFO. The search of surgical papers
was restricted to studies published from
2008 onwards, given that 2 systematic re-
views had been published on surgical
management of TN.6,7 Furthermore,
international guidelines on the surgical
management of TN8 and a review of
quality of reporting of surgical studies,
which reviewed the literature up to
2008,9 also had been published. The
search strategy for MEDLINE AND
EMBASE can be found in Appendix A.
Eligibility Criteria
The inclusion criteria were as follows: 1)
intervention studies with a cohort of pa-
tients diagnosed with TN; 2) medical and/
or surgical intervention; 3) TN cohort 10
patients; 4) subjects aged 18 years and
older; 5) English language; and 6) full text
available.
No discrimination was made concern-
ing the study design, as the aim was to
capture all the treatment outcomes and
outcomes measures published to date.
Studies in which there were 2 or more
cohorts (TN and hemifacial spasm, for
example) were included but only data
relevant to the TN cohort was evaluated.
Screening
The references were organized in EndNote
X9 and duplicates removed. Initially, 25
study titles were piloted between 2 re-
viewers (C.V.N. and R.N.R.). The inter-
rater agreement was 0.60. Following dis-
cussion and modification of the piloting
sheet to include abstracts, the process was
repeated with 50 further studies. The final
Kappa coefficient was 0.80.
The body of references was then
screened on title and abstract; if no
consensus was reached, a third reviewer
(J.M.Z.) made the final decision. Three
reviewers (C.V.N., R.N.R., and J.M.Z.)
subsequently screened full texts, if avail-
able, against eligibility criteria.
Data Collection and Synthesis
We have used EPPI-Reviewer 4 software10
to extract data from the final selected
references. Data were extracted by 3
reviewers (C.V.N., R.N.R., and J.M.Z.)
on TN classification (classical, idiopathic,
and secondary to neurologic disease,
Burchiel classification, and unspecified),
cohort type (prospective, retrospective,
and unspecified), intervention (medical
and/or surgical), and treatment outcomes
(domain, dimension, and instruments).
Data on outcome domains were
captured according to the IMMPACT rec-
ommendations.4 This review includes
studies that precede those
recommendations, as well as study
designs other than clinical trials, but it
was decided to use their guidance for a
clear and standardized organization of
the results. Treatment outcome measures
were identified, and where available, data
were collected on outcome measure
instruments. The complete data
extraction code can be found in
Appendix B.
Statistical Analysis
Descriptive statistical analysis was per-
formed to summarize the number of times
outcomes and outcome measures were
reported in the TN literature.
RESULTS
Four hundred sixty-seven (n ¼ 467) papers
were included in the final review and
grouped according to TN classification,
method of data collection, treatment
intervention, and treatment outcomes
(domain, dimension, and instruments/
measures). Figure 1 illustrates the flow
chart of references.11
TN Classification
Just less than one half of the papers (47%)
described their TN cohort as classic,
idiopathic, secondary to neurologic dis-
ease or used the Burchiel classification.12
One hundred twenty (n ¼ 120) studies
did not specify the type of TN in their
cohort and 47 others used a
nomenclature that was not clearly
defined, e.g., refractory TN, medically
unresponsive TN, and recurrent TN after
microvascular decompression (MVD).
Method of Outcome Data Collection
More than one half of the studies reviewed
(n ¼ 254) collected their data retrospec-
tively. Data were collected prospectively in
131 studies and 81 did not specify how
their data were collected.
Intervention
Treatment interventions were divided into
medical and surgical; however, data were
not collected on the specific medical and
surgical treatment modalities. The use of
systemic and topical medicines and
botulin toxin were included in medical
management and all the ablative tech-
niques,7 neurosurgical procedures (MVD),
and laser treatment in surgical
management. The majority of studies
reviewed were surgical papers (n ¼ 398)
and a minority combined medical and
surgical treatment (n ¼ 10).
Outcome Domains, Dimensions, and
Measures
For systematization and clarity, outcome
data were organized and mapped to the
IMMPACT outcome domain recommen-
dations for clinical trials in chronic pain
(Figure 2).4 Only 42 of the 467 reviewed
studies were published during or before
2003, predating the IMMPACT
publication. The IMMPACT Outcome
Domains are as follows: 1) Pain; 2)
Physical functioning; 3) Emotional
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•
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•
•
•
•
•
•
•
Age < 18ys (n=1)
Animal studies (n=1)
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Conference abstracts/ 
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editorials (n=16)
Full text not available (n=48)
Full text not in English (n=2)
Not intervention studies (n=59)
Not TN (n=29)
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Technical surgical papers 
(n=39)
Studies included in narrative 
synthesis 
(n=467)
Records excluded (n = 4376)
•
•
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•
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Abstract not available (n=115)
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Anatomy studies (n=77)
Animal studies/basic science 
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Conference abstracts/ 
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editorials (n=972)
Facial pain overview (n=352)
Full text not in English (n=23)
Imaging studies (n=154)
Not TN (n=1127)
Pharmacology (n=194)
SRs, MA and protocols (n=49)
Technical surgical papers 
(n=216)
Figure 1. Systematic review flow chart. (Adapted from Moher et al.11)
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functioning; 4) Participant ratings of
global improvement/satisfaction; 5)
Symptoms and adverse events; and 6)
Participant disposition.
With the exception of 8 papers, all
studies used pain as an outcome domain
(Figure 2 and Table 1).13-459 Symptoms and
adverse events also were described in a
high number of papers (n ¼ 386);
however, the impact of treatment on
physical and emotional functioning was
significantly less evaluated, in 46 and
17 studies, respectively (Tables 2 and
3).460-464 Of the 334 surgical studies that
described adverse events, only 62
mentioned mortality rates. Participant
disposition was described in 16 studies
(3%).
Pain
Pain Relief. Pain relief was used as an
outcome dimension in the majority of
studies (n ¼ 314). Ten different outcome
measures were used for pain relief and 78
of 314 (25%) studies did not use an
outcome measure. The Barrow Neurology
Institute Pain Intensity Scale (BNI) was the
most used pain relief measure in 131 of
studies (42%), followed by a Likert scale in
76 (24%) and the visual analogue scale
(VAS) in 18 (6%).
Pain Intensity. Pain intensity was used as a
treatment outcome dimension in 193 of
the 459 studies describing pain as an
outcome domain. There were 9 different
measures used for pain intensity and 8
studies did not use any. The VAS was the
most commonly used measure in 85
studies followed by the BNI (n ¼ 45) and
the use of qualitative pain descriptors (n ¼
32).
Pain Frequency. Only 27 of 459 studies
(6%) used pain frequency as a treatment
outcome dimension. The majority did not
use an outcome measure (n ¼ 15) and 10
indicated the use of a pain diary. One
study used a pain vector diagram and
another study used The Constant Face
Pain Questionnaire.
Physical Functioning
Forty-six studies included at least 1 mea-
sure for evaluating physical functioning
dimensions, such as quality of life (QOL;
n ¼ 34), daily activities (n ¼ 9), pain
interference (n ¼ 4), ability to work (n ¼
2), and disability (n ¼ 1). These are sum-
marized in Table 2 with the references.
Quality of Life. The most used instrument
for assessing impact on QOL was the 36-
Item Short form Survey Instrument (n ¼
14), followed by the EQ-5D (5-Question
Quality Of Life Instrument) (n ¼ 4), Sick-
ness Impact Profile (n ¼ 2), and Brief Pain
Inventory (BPI) (n ¼ 2). The World Health
Organization Quality of Life and 12-Item
Short Form Health Survey were used in 1
study each. Of note, the BPI facial was
used only once.
Two studies did not use an outcome
measure and 8 used a different measure
(Quality of Life Impact Scale, 0e100 scale
(2 studies used this measure), Trigeminal
Neuralgia Quality of Life Assessment
Scale, Epilepsy Surgery Inventory-55, 10-
point Quality of Life Scale, Wong Baker
FACES scale, and a 5-Point Scale).
Daily Activities. Activities of daily living
was the most commonly used instrument
(n ¼ 4) followed by the Penn Facial Pain
scale (n ¼ 1). One study did not use an
outcome measure and 4 studies used
different measures (Brief Fatigue In-
ventory, Karnofsky Performance Status
Scale, Category Point Scale, yes/no
questionnaire).
Pain Interference. The only instrument
used to evaluate pain interference was the
BPI facial (n ¼ 4), which is the only in-
strument specific for facial pain.
Ability to Work. Only 2 measures were
used to evaluate ability to work; one study
used a Likert scale and a second study
used the Self Perceived Productivity Scale.
Disability. The Pain Disability Index was
used in 1 study only.
Emotional Functioning
Three dimensions were assessed in this
domain: depression (n ¼ 5), anxiety (n ¼
3), and catastrophizing (n ¼ 1). Some
studies combined anxiety and depression
(n ¼ 12). Please refer to Table 3 for
references.
Anxiety and Depression. The combination
of anxiety and depression was evaluated by
the use of Hospital Anxiety and Depres-
sion Scale in 9 studies, and 1 study did not
use an outcome measure. One other
measure was found in 2 studies—the
Research Diagnostic Criteria.
Depression. To evaluate depression alone,
the Beck Depression Inventory was used in
3 studies followed by the Hamilton
Depression Scale (n ¼ 1) and the Patient
Health Questionnaire-9 (n ¼ 1).
Anxiety. To evaluate anxiety, only 2 in-
struments were used, the Beck Anxiety
Inventory (n ¼ 2) and the Hamilton Anx-
iety Scale (n ¼ 1).
Catastrophizing. Only one study evaluated
catastrophizing, with the aid of the Pain
Catastrophizing Scale.
 ? ?
 ? ?
 ? ?
 ? ?
 ? ? ?
 ? ? ?
 ?  ? ?  ? ? ?  ? ? ?  ? ? ?  ? ? ?  ? ? ?  ? ? ?  ? ? ?  ? ? ?  ? ? ?
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Figure 2. Number of studies divided according to IMMPACT recommendations on Outcome
Domains.4
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Satisfaction with Treatment
Only 35 studies (7%) reported on patient
ratings of improvement and satisfaction
with treatment. The majority of studies
(n ¼ 17) used a Likert Scale to rate their
patient satisfaction with treatment,
whereas 2 studies used a Patient Satisfac-
tion Scale and one other a VAS scale. Nine
studies used the Patient Global Impres-
sion of Change to rate change with treat-
ment. Three studies did not use an
outcome measure and 4 studies used 4
other outcome measures (QUASU - Satis-
faction with Treatment and Medical Team;
Satisfaction Survey; The Patient Global
Rating of Efficacy and Safety; and The
Wong Baker FACES scale).
Adverse Events
Data on adverse events and side effects
were collected in 83% of the studies. Of the
59 medical studies, 85% described side ef-
fects. Outcome measures were used in only
3 studies—The Liverpool Adverse Event
Profile (n ¼ 2) and the A-B Neuropsycho-
logical Assessment Schedule (n ¼ 1).
On the surgical studies group, side ef-
fects and adverse events were collected in
334 (84%). The most reported side effect
was numbness (n ¼ 220) and the Barrow
Neurology Institute Numbness Scale was
administered in 62 studies. A Likert scale
was used once to assess degree of numb-
ness. One other surgical study used the
Landriel Ibanez classification, but the
majority of studies limited their reporting
to the passive description of the cohort
side effects opposed to using an instru-
ment to collect the data.
Patient Disposition
Patient disposition is not considered a
treatment outcome. This domain refers to
the patient navigating through a study and
often presented in a flow diagram.
Guidance on reporting for the different
types of studies has been published by the
EQUATOR Network (Enhancing the
QUAlity and Transparency Of health
Research) (https://www.equator-network.
org/) and endorsed by medical and surgi-
cal journals.9 It has been accepted that the
Table 1. Pain Dimensions and Outcome Measures Identified in the Systematic Review
Outcome Dimension Outcome Measure Reference Numbers
Pain relief
(314)
Barrow Neurology Institute Pain Intensity Scale (BNI) 13-143
No outcome measure 144-221
Likert scale 66,219,222-295
Visual analogue scale (VAS) 13,294,296-311
Numeric Rating Scale (NRS) 296,312-316
Modified BNI 317,318
Marseille scale 41,63,319
MVD evaluation score 320,321
Regis classification 112,322
Burchiel classification 323
Other 324
Pain intensity
(193)
VAS 32,42,96,123,124,145,164,168-170,195,219,220,241,248,295,298,299,301,302,304-307,309,310,325-383
BNI 15,22,39,44,46,49,55,56,62,68,74,82,127,128,195,202,210,339,355,360-362,384-406
Qualitative pain descriptors 150,184,186,188,191,192,218,295,366,385,407-428
NRS 31,35,71,145,235,266,278,298,304,314-316,413,429-440
Brief Pain Inventory (BPI) 34,48,127,311,438,441-447
McGill Pain Questionnaire 22,214,241,278,344,356,357,446-448
No outcome measure 116,117,225,292,449-452
Verbal Pain Scale (VPS) 214,295,363,367,409,453,454
Verbal Numeric Pain Scale (VNPS) 49,188,455
Other 324
Pain frequency
(27)
No outcome measure 159,160,207,208,349,350,354,373,432,433,444,452,456-458
Pain diary 188,278,292,295,309,330,376,380,438,459
Pain vector diagram 453
The Constant Face Pain Questionnaire 241
MVD, microvascular decompression.
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reporting of the patient progression in
clinical trials should be illustrated by a
CONSORT diagram (Consolidated
Standards of Reporting Trials)465 and, in
the case of observational trials, the
STROBE statement (Strengthening the
Reporting of Observational studies in
Epidemiology) should be followed.466
In this review, we have identified 16
studies in which there was information
about patient progression—CONSORT dia-
gram (n¼ 4), STROBE reporting (n¼ 5) and
7 illustrated their informationwitha diagram
but did not follow any specific guidance.
DISCUSSION
This systematic review provides a sum-
mary of the outcomes and outcome
measures that have been used in the
medical and surgical treatment of TN to
date, performed by clinicians from varied
backgrounds, and it highlights the vari-
ability in the methodology of studies and
choice of outcome measures employed.
Pain: Outcome Dimensions and Outcome
Measures
The degree of pain relief as well as the level
of pain intensity have been the most
commonly used dimensions in chronic
pain studies.467,468 Similar to what others
have found in the TN surgical
literature,6,7,9 the most common pain
dimension reported was pain relief. In the
context of TN, however, there seems to be
no consensus in what should be the
primary outcome dimension in trials of
TN. Studies that use either pain intensity
or pain relief as their outcome of interest
are difficult to compare. Pain intensity
refers to “how intense the pain is,”
whereas pain relief refers to “how much
pain relief” has resulted from a certain
treatment and so requires a baseline
assessment.469 Some authors have
attempted to clarify if pain relief ratings
and pain intensity ratings are comparable.
For example, Jensen et al.470 looked at a
cohort of 248 postsurgical patients (knee
replacement vs. laparoscopy) whose
outcomes were pain intensity (VAS and
Verbal Rating Scale) and pain relief (VAS).
They had hypothesized that the
differences in sensitivity to detect change
would be similar in both cohorts;
however, this was not supported. They
Table 2. Physical Functioning Domain and Outcome Measures Identified in the Systematic Review
Outcome Dimension Outcome Measure Reference Number
Quality of life
(34)
36-Item Short form Survey Instrument (SF-36) 41,122,124,344,354,355,360,361,382,425,444,446,460,461
5-Question Quality of Life Instrument (EQ-5D) 67,266,356,391
Sickness Impact Profile 349,432
Brief Pain Inventory 73,344
World Health Organization Quality of Life (WHOQOL-100) 35
Brief Pain Inventory Facial 462
12-Item Short Form Health Survey (SF-12) 463
Quality of Life Impact Scale 332
0e100 Scale 71,170
Wong Baker FACES scale 324
Trigeminal Neuralgia Quality of Life Assessment Scale 261
Epilepsy Surgery Inventory-55 362
5-Point Scale 214
10-Point Quality of Life Scale 364
Daily activities
(9)
Activities of Daily Living 41,278,357,413
Penn Facial Pain Scale 464
Karnofksy Performance Status Scale 41
Brief Fatigue Inventory 443
Category Point Scale (CPS) 367
Yes/no questionnaire 292
Pain interference
(4)
Brief Pain InventoryeFacial (BPI-Facial) 64,72,442,445
Ability to work
(2)
Likert scale 391
Self-Perceived Productivity Scale 357
Disability
(1)
Pain Disability Index 356
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have confirmed that even though related,
pain relief and intensity mean slightly
different things, as patients report pain
relief even when pain intensity ratings are
the same or even greater than presurgery.
Their conclusions point to the need of a
clear definition of the primary outcome
and a clear choice of a validated tool
capable of capturing it.470 In addition,
pain intensity may remain the same but
patient’s ability to cope with it may
change, and this would be reflected in
measures looking at aspects such as
activities of daily living. Baseline data
before surgical procedures are rarely
reported and yet they are crucial to
determine the true impact of a treatment.
TN is an episodic pain; it is interesting to
see that little attention is given to this
specific characteristic. To date, no
instruments have been designed to
capture the effects of treatment on the
number and frequency of TN attacks.
Degn and Brennum453 have attempted to
capture these data in a cohort of patients
undergoing glycerol injection, MVD, and
rhizotomy by plotting pain intensity
(Verbal Numerical Rating Scale) with
frequency of daily pain per month. Their
data were used to design a pain vector
diagram to illustrate, in a composite
outcome, the effects of treatment.
Another temporal aspect of pain is
duration of pain-free status over time,
which has been illustrated in the literature
with KaplaneMeier survival curves.9 It is
almost certain that patients would value
information about which treatment
provides absence of pain for the longest
period of time, and it might be that
plotting pain relief outcome data over
time is the correct way of doing it,
however, rigorous reporting of follow-up
times are essential for data accuracy.
The VAS and BNI intensity scales are
the most used tools to capture data on
pain intensity. Both scales also were used
to retrieve information on pain relief.
Given that VAS is a single-item scale and
BNI is a composite scale, it is not possible
to compare data captured by these in-
struments, especially as they are
measuring different pain dimensions and
the BNI includes data on medication use.
Despite their wide use in TN, neither the
VAS nor the BNI have been validated for
their use in TN cohorts.7,471,472 It is not
clear whether patients complete the
scales or whether the data are retrieved
from the medical records.
Finally, we should stress that the use of
outcomes that are designed specifically for
a single study, or which have been modi-
fied and derived from other instruments,
for example modified BNI317,318 and have
not been validated for TN are neither
reliable nor reproducible and comparison
of study results is flawed.
Data-Collection Method
The retrospective collection of data, spe-
cifically, the interviewing of patients,
months or years after their treatments
were done, raises the question of recall
bias and it can be influenced, for example,
by severity of pain at time of recall.473
Of note, in one of the studies, family
members of deceased patients were
contacted to obtain information about
their condition.235 The experience of pain
is a very personal one and it is
unreasonable to expect that others can
provide information, except if stated
early on, that the outcome collected is
not patient reported. If the information
sought is related to effects of treatment
on someone’s level of pain, then the
patient is the only valid source of
information.474
Domains Other Than Pain
There has been extensive research high-
lighting the impact of chronic pain inmood
and QOL.475 Tölle et al.476 and Zakrzewska
et al.447 described the high impact of TN
pain on activities of daily living as well as
on emotional functioning; however, the
reporting of TN impact on QOL has been
sparse.477 Of the 8 different instruments
used for emotional functioning, only one,
the Hospital Anxiety and Depression
Scale, has been validated for TN. The BPI
facial has been validated in a cohort of
patients with TN,478 but its uptake, in
studies published since 2010 and included
in this review, is low, being used in 4
studies to assess pain
interference64,72,442,445 and in one to
assess impact on QOL.462 Interpreting the
effects of TN on the emotional and
physical health will also depend on the
appropriateness of these instruments for
their use in a TN cohort.
The reporting of side effects should go
beyond a narrative list and incorporate how
individual side effectsmight affect patients’
QOL or what the impact on daily living is.
As illustrated by Akram et al.,9 the side
effects of treatment might impact more on
a patient’s QOL than the pain itself.
There might be a few practical expla-
nations for the poor reporting on domains
other than pain. First, reporting on mul-
tiple outcome domains would require
more comprehensive questionnaire(s) that
could be a burden to patients, risking a
poor response rate and validity of results.
Second, time might be a limiting factor for
researchers who need to administer,
collect and analyze all the data. Patients
may not be made aware of their relevance
and so not complete them. Finally,
although attempts have been made to
improve reporting of outcomes in studies
on TN, journal editors have not insisted on
more comprehensive reporting.9
Table 3. Emotional Functioning Domain and Outcome Measures Identified in the
Systematic Review
Outcome Dimension Outcome Measure Reference Number
Anxiety and depression
(12)
Hospital Anxiety and Depression Scale (HADS) 214,344,356,432,446-448,462,463
Research Diagnostic Criteria (RCD) 341,342
No outcome measure 82
Depression
(5)
Beck Depression Inventory (BDI) 335,372,444
Hamilton Depression (HDRS) 354
Patient Health Questionnaire-9 (PHQ9) 67
Anxiety
(3)
Beck Anxiety Inventory (BAI) 335,372
Hamilton Anxiety Scale (HARS) 354
Catastrophizing
(1)
Pain Catastrophizing Scale (PCS) 447
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Limitations
The inclusion of a large number of studies
to summarize information on outcomes
and outcome measures in the treatment of
TN created a heterogeneous data set,
which was challenging to organize. The
studies were not appraised on their sci-
entific rigor, as we wanted to capture the
diversity of outcomes and outcome mea-
sures available in the literature. Due to the
volume of results, our data extraction on
outcomes was limited to identifying the
outcome measure instrument used and for
the majority of the studies we failed to
retrieve information concerning the
timing and method of questionnaire
administration. Although guidance from
IMMPACT is to be considered in clinical
trials, due to the lack of available guidance
for the reporting of outcomes in TN
studies, we decided to map our results to
their recommended 6 core domains. We
acknowledge that these outcomes might
not comprehensively reflect the ones pa-
tients with TN consider important and
that fewer may be required when reporting
other types of studies. Finally, our search
included English-language literature only,
and we might have left out relevant
research published in other languages
(language bias).
Recommendations for Future Research
Following this work, it is our aim to
develop a Core Outcome Set (COS) for the
treatment of TN. COS is a group of
defined outcomes that should be consis-
tently collected and measured in all trials
of a specific condition.479
We aim to seek guidance from
IMMPACT, where possible, but we will not
limit it to this, as there might be other
outcome dimensions relevant to the TN
population, for example, frequency of pain
episodes, duration of pain-free episodes,
and fear of attacks in between episodes.
We will also follow recommendation from
COMET (Core Outcome Measures in
Effectiveness Trials) and COSMIN
(COnsensus-based Standards for the se-
lection of health Measurement In-
struments) initiatives for methodological
guidance.480 One of the fundamental steps
in the COS-development process will be to
confirm whether patient’s views on out-
comes map to the currently used in-
struments and if not, the validity of tools
needs to be tested for their ability to detect
change over time—what is the value of a
composite measure opposed to a single
item measure? For example, patient global
impression of change may cover all the
required features and has been shown to
be useful in neuropathic pain.481
A TN COS could be used in all pro-
spective trials and could consistently cap-
ture data that can be compared between
studies improving patient health and
reducing health care expenditure. We
acknowledge the complexity of this pro-
cess and that it will take time to take into
account all stakeholders views.
CONCLUSIONS
Patients and clinicians currently have no
reliable way of comparing outcomes in TN
especially between medical or surgical
treatments. Trials of medical therapies are
said to be positive if 50% of patients are
pain free,482 whereas surgical outcomes
require 100% pain relief if they are said
to be successful.
The variability in the reporting out-
comes as well as the lack of validation of
the instruments highlights the need for a
partnership between different stake-
holders—patients, patient groups, clini-
cians, researchers—in the preparation of a
well-defined core set of outcomes and
there are examples in the chronic pain
field where this partnership has proved to
be successful.483,484
Until there is a rigorous process for
gathering TN treatment outcome data,
which includes defining the primary
outcome of importance to patients, the
lack of consistency between studies will
continue to account for the difficulties
patients and clinicians have in identifying
the best treatment option for each indi-
vidual patient as this can vary significantly.
This is of particular importance, given the
range of treatments currently available for
TN and, in addition, as not all patients opt
for surgical therapies.
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